Cencora Inc. (COR)

Cencora (COR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here is how Cencora (COR) and Intensity Therapeutics Inc. (INTS) have performed compared to their sector so far this year.

Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Here, we discuss three medical device stocks ,COR, HIMS and PBH, that offer cheap valuations, making them attractive bets amid tariff risks.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

VANCOUVER, BC / ACCESS Newswire / April 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ( "Camino" or the "Company" ) is pleased to announce the completion of its previously announce...

COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

In the present market turbulence, investors may want to consider discounted stocks, such as FMS, PAHC and COR.

Fear and uncertainty have dominated the markets in 2025, with U.S. equities entering a significant correction. What began as a cautious retreat in February, sparked by policy concerns and underwhelmin...

Cencora hit an all-time high on Friday. The post Sellers Rule The Roost Amid Tariff Wars, But This Stock Hits A High appeared first on Investor's Business Daily.